Overactivation of PERK signalling is a feature of post-mortem brains of patients with Alzheimer's and Parkinson's diseases and the tauopathies, frontotemporal dementia (FTD) and Progressive Supranuclear Palsy (reviewed in Scheper and Hoozemans2). The gene discussed is EIF2AK3; the disease is Parkinson disease.